Salofalk contains the active substance mesalazine (also known as mesalamine), which belongs to a group of medicines called aminosalicylates. These medicines are designed to reduce inflammation directly at the intestinal lining.

Salofalk tablets are used for the treatment of acute episodes of mild to moderate ulcerative colitis, a chronic inflammatory disease affecting the colon.

Salofalk may be prescribed for the following therapeutic purposes:

• Treatment of active ulcerative colitis

• Reduction of inflammation in the large intestine

• Support of symptom control during disease flare-ups

Mesalazine ulcerative colitis therapy works locally in the gut rather than systemically, which helps limit unwanted effects elsewhere in the body.